SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate change

13 Jan 2026 07:00

RNS Number : 5989O
Rentokil Initial PLC
13 January 2026
 

13 January 2026

Rentokil Initial plc appoints Mike Duffy as Chief Executive

Rentokil Initial plc (LSE: RTO, NYSE: RTO) ("the Company") today announces the appointment of Mike Duffy (Michael A. Duffy) as Chief Executive (CEO) and an Executive Director, effective 16 March 2026. He will join the Company on 16 February 2026 as CEO Designate.

Mike succeeds Andy Ransom, who will step down as CEO and Executive Director on 16 March 2026 and will continue to work with the Company to ensure a smooth transition ahead of the Company's AGM on 7 May 2026.

Mike, a US citizen, will be based in North America. He brings 25+ years of leadership experience with large US businesses across B2B and B2C industries. Throughout his career, he has delivered successful business transformations through initiatives to improve the customer experience, employee engagement and financial returns. These initiatives include optimising commercial strategy, deploying technology to enhance the customer experience, and driving more robust processes and culture

Mike is currently CEO of OnTrac, an American logistics company specialising in residential last-mile deliveries for e-commerce and direct-to-consumer brands, where he has established a culture of sales excellence and refocused the business on mutli-site efficiency with investments in technology and best-in-class operations. Prior to this he was the CEO of FleetPride, Inc., the largest independent B2B distributor of parts and a full-service provider for the US heavy-duty truck industry which under Mike's leadership had over 350 locations across North America. Both OnTrac and FleetPride are owned by the US-based private equity business, American Securities LLC.

Richard Solomons, Chair of Rentokil Initial plc, said:

"We are delighted to announce Mike as our new Chief Executive. He is a successful business leader with a deep understanding of multi-site and route-based operations and customer acquisition strategies. He has a proven track record of delivering profitable growth and transforming businesses and has the right skills and capabilities to enable Rentokil Initial to realise its full potential over the coming years.

"On behalf of the Board, I want to express our gratitude to Andy for his enormous contributions and commitment to the Company for 18 years and especially during his successful tenure as CEO, steering Rentokil Initial to become one of the world's leading services businesses. We wish him all the very best for the future."

Mike Duffy said:

"It is an honour to be appointed as Chief Executive of Rentokil Initial, a company with an impressive global footprint and a leading position in the North American market. I admire Rentokil Initial's commitment to its customers, its focus on innovation, and the dedication of its people. There is an exciting opportunity ahead to build upon the strong foundations in place to drive operational excellence, improved financial performance and incremental value for shareholders."

Andy Ransom said:

"It has been the greatest privilege of my career to lead Rentokil Initial, and I want to extend my deepest thanks to every colleague who has contributed to our success. We have built the world's largest Pest Control business, which, together with our global Hygiene and Wellbeing business, are a platform with the scale and capabilities to drive future growth. I am immensely proud of what we've accomplished, and I look forward to handing the baton over to Mike and working closely with him to ensure a smooth transition."

The Company will announce its financial results for the Full Year 2025 on 5 March 2026. Andy Ransom, CEO, and Paul Edgecliffe-Johnson, CFO, will update the market, before Andy hands over to Mike on 16 March 2026.

Notes:

Mike Duffy - Career Details:

 2023-now: Chief Executive Officer, OnTrac

OnTrac is an American logistics company that primarily services e-commerce retailers and direct-to-consumer brands. Mike was appointed CEO in March 2023, following OnTrac's acquisition by LaserShip. He transformed operations to refocus on multi-site efficiency and investments in technology. The business is primarily residential, providing last-mile deliveries.

2021-2023: Chief Executive Officer, FleetPride, Inc.

FleetPride, Inc., is the largest independent distributor of parts and a full-service provider for the U.S. heavy-duty truck industry operating from over 350 locations by the end of Mike's tenure. Mike delivered strong growth through network expansion, disciplined pricing, and 25+ bolt-on acquisitions. He repositioned the commercial strategy towards higher-margin services and developed an industry-leading e-commerce platform.

 2018-2020 Chief Executive Officer, C&S Wholesale Grocers, LLC

C&S Wholesale Grocers, LLC is a leading US grocery wholesale distributor delivering over 100,000 unique products to more than 7,500 grocery stores from 60 distribution centres across the US. During his time as CEO, Mike simplified the business's portfolio and redeployed capital towards core growth segments.

2006-2017 Cardinal Health, Inc.

2015-2017: President, Hospital Solutions and Global Supply Chain, part of a $13bn revenue division, where Mike focused on three major initiatives for its transformation: keeping customers as the sole focal point of the organisation, achieving cost leadership across the value chain, and leveraging best practices and skills across the organisation. He also overhauled Cardinal's brand strategy and expanded operations in Asia to fully leverage growth opportunities, primarily in Malaysia, Singapore and Shanghai.

2013-2015, President, Medical Products

2006-2013, Executive Vice President, Global Manufacturing and Supply Chain, Medical

2001-2006: Vice President, Global Supply Chain, The Gillette Company

 1997-2001: Consultant, Supply Chain and Operations, New York Consulting Partners Inc.

Boards: Since July 2020, Mike has served on the board of Republic Services, Inc., a publicly listed waste management company with a market capitalisation of $65bn, where he is a member of both the Audit and Sustainability & Corporate Responsibility committees. He was a Board member as CEO at C&S Wholesale. He is on the Board for FleetPride and will step down from this role when he joins the Company.

Education: He holds a bachelor's degree in operations research and a master's degree in transportation from the Massachusetts Institute of Technology.

Remuneration: All remuneration arrangements are in line with the shareholder approved Directors Remuneration Policy (the "Policy"). Mike will receive an annual salary of US$1,600,000 and will be eligible for an annual bonus with a maximum opportunity of 225% of base salary and long-term incentive plan awards with a maximum grant date value of 375% of base salary. He will also be eligible to receive benefits and pension in accordance with the Policy.

In addition, the Company will compensate Mike for certain remuneration he will forfeit as a result of leaving his current role. He will be compensated for his 2025 annual bonus and long-term incentive awards forfeited. He will receive a cash payment in lieu of his annual bonus expected for 2025 once the value has been confirmed.

In respect of the long-term incentive awards he forfeits, he will receive three replacement awards over Rentokil Initial shares with an aggregate maximum grant date value of US$3.98m. These awards are broken down as follows: the first award will have a grant date value of US$1.26m, and the second will have a maximum grant date value of US$720k. For both of these awards, half will vest two years after the relevant grant date and the other half will vest three years after the grant date. The third award will have a grant date value of US$2m and will vest three years after the grant date, subject to the achievement of performance conditions related to Rentokil Initial share price growth. All replacement awards will be subject to clawback and malus provisions.

Mike will be subject to Rentokil Initial's minimum shareholding requirement of 400% of salary and post-employment shareholding requirements.

Full details of Mike's remuneration will be set out in the Company's 2025 Directors Remuneration Report.

There are no further details to be disclosed relating to Mike Duffy under Listing Rule 6.4.8.

For further information, please contact:

Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

About Rentokil Initial plc:

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs over 60,000 people in around 90 countries.

www.rentokil-initial.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQGGUPQPGP
Date   Source Headline
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company
14th Oct 20229:30 amRNSAdditional Listing
13th Oct 20225:42 pmRNSHolding(s) in Company
13th Oct 20223:05 pmRNSHolding(s) in Company
12th Oct 20221:53 pmRNSAcquisition of Terminix Completion
10th Oct 20221:57 pmRNSHolding(s) in Company
10th Oct 20221:52 pmRNSHolding(s) in Company
10th Oct 20221:38 pmRNSHolding(s) in Company
7th Oct 20226:10 pmRNSRentokil Initial
6th Oct 20222:23 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.